Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Early summer should see the publication of a detailed analysis from the estrogen-alone arm of the Women’s Health Initiative (WHI). The study was suspended in February when scientists determined the therapy did not appear to affect heart disease, the major question being evaluated in the trial.

Estrogen arm of WHI suspended; what next?